糖尿病肾病中医药治法探析
Analysis of Traditional Chinese Medicine Treatment of Diabetic Nephropathy
DOI: 10.12677/TCM.2023.127268, PDF,   
作者: 郝傲寒：湖北中医药大学，中医临床学院，湖北 武汉；韦 伟：湖北中医药大学，针灸骨伤学院，湖北 武汉
关键词: 糖尿病肾病；病因病机；辨证分型；中医药治疗；综述；Diabetic Nephropathy； Etiology and Pathogenesis； Syndrome Differentiation； Chinese Medicine Treatment； Review
摘要: 糖尿病肾病(Diabetic Nephropathy, DN)是一种糖尿病引起的肾脏病变，是导致我国成人肾衰竭的常见原因，临床上严重影响着患者的健康与生活。中医治疗DN有以下优势：① 中药可有效控制血糖，减少胰岛素用量；② 可显著减少蛋白尿，消除患者水肿；③ 肾功能不全者，可通过中医外治法延缓肾衰竭进程，提高生活质量。本文从病因病机、辨证分型、中医药治疗等方面阐述糖尿病肾病的中医临床研究，并归纳整理、系统分析如下。
Abstract: Diabetic nephropathy (DN) is a kind of renal disease caused by diabetes. It is the common cause of adult renal failure in our country, which seriously affects the health and life of patients.TCM treatment of DN has the following advantages: 1) TCM can effectively control blood sugar and reduce insulin dosage; 2) It can significantly reduce proteinuria and eliminate edema; 3) For pa-tients with renal insufficiency, external treatment of traditional Chinese medicine can be used to delay the process of renal failure and improve the quality of life. This paper expounds the TCM clinical research of diabetic nephropathy from the aspects of etiology, pathogenesis, syndrome differentiation and TCM treatment, and summarizes and systematically analyzes the following.
文章引用：郝傲寒, 韦伟. 糖尿病肾病中医药治法探析[J]. 中医学, 2023, 12(7): 1796-1802. https://doi.org/10.12677/TCM.2023.127268

参考文献

[1] Saeedi, P., Petersohn, I., Salpea, P., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results From the International Diabetes Federation Diabetes Atlas, 9th Edition. Di-abetes Research and Clinical Practice, 157, Article 107843. [Google Scholar] [CrossRef] [PubMed]
[2] Marathe, P.H., Gao, H.X. and Close, K.L. (2017) American Diabetes Association Standards of Medical Care in Diabetes 2017. Journal of Diabetes, 9, 320-324. [Google Scholar] [CrossRef] [PubMed]
[3] F Halperin, X Lopez, R Manning. 胰岛素抵抗者的葡萄糖刺激胰岛素分泌的增强作用受损[J]. 中国糖尿病杂志, 2012, 22(1): 6.
[4] 刘建强, 贾冶, 许钟镐, 等. 肥胖与慢性肾脏疾病: 脂肪组织与肾脏炎症及纤维化的关系[J]. 中华肾脏病杂志, 2017, 33(12): 956.
[5] 孙珺, 郭兆安. 肾脏疾病中线粒体脂代谢与脂毒性的研究进展[J]. 生命的化学, 2023, 43(4): 549-557.
[6] Wexler, D.J., de Boer, I.H., Ghosh, A., Younes, N., Bebu, I., Inzucchi, S.E., McGill, J.B., Mudaliar, S., Schade, D., Steffes, M.W., Tamborlane, W.V., Tan, M.H., Ismail-Beigi, F. and GRADE Research Group (2023) Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial. JAMA Internal Medicine, 183, 705-714. [Google Scholar] [CrossRef] [PubMed]
[7] Chen, L., Sha, M., Chen, F., Jiang, C., et al. (2022) Upregulation of KLF14 Expression Attenuates Kidney Fibrosis by Inducing PPARα-Mediated Fatty Acid Oxidation. Free Radical Biology & Medicine, 195, 132-144. [Google Scholar] [CrossRef] [PubMed]
[8] Liu, Y., Chen, Y., Yang, Q., Shen, D., et al. (2022) Single Nucleotide Polymorphisms in the GFR-Related Gene and the SNP-SNP Interactions on the Risk of Diabetic Kidney Disease in Chinese Han Population. Acta Diabetologica, 60, 115-125. [Google Scholar] [CrossRef] [PubMed]
[9] Pang, X., Hou, X., Hu, C., Lu, S., et al. (2023) Tenascin-C Promotes the Proliferation and Fibrosis of Mesangial Cells in Diabetic Nephropathy through the β-Catenin Pathway. International Urology and Nephrology. [Google Scholar] [CrossRef] [PubMed]
[10] 周强. 仝小林教授治疗糖尿病肾病用药规律分析及经验总结[D]: [硕士学位论文]. 北京: 中国中医科学院, 2011.
[11] 张勉之, 李树茂, 何璇. 张大宁名老中医学术思想及思辨特点研究报告[J]. 中国中西医结合肾病杂志, 2012, 13(8): 662-665.
[12] 谢绍锋, 黄莉吉, 余江毅. 湿热瘀血与糖尿病肾病蛋白尿关系探讨[J]. 南京中医药大学学报, 2012, 28(6): 506-508.
[13] 南征. 消渴肾病(糖尿病肾病)研究[M]. 长春: 吉林科学技术出版社, 2001: 3.
[14] 牟新, 周迪夷, 庄爱文, 等. 2型糖尿病和糖尿病肾病人群的中医证候演变规律[J]. 中华中医药杂志, 2016, 31(9): 3707-3710.
[15] 沈翊, 李传平. 李传平辨治糖尿病肾病经验[J]. 中医药临床杂志, 2017, 29(7): 995-997.
[16] 姚洁琼, 王耀献. 王耀献从热分期治疗糖尿病肾病经验[J]. 国医论坛, 2016(3): 32-33.
[17] 张英杰. 中医辨证论治糖尿病肾病38例的疗效观察[J]. 世界最新医学信息文摘(连续型电子期刊), 2016, 16(68): 118-118.
[18] 盛凌敏. 中医辨证分型加减治疗糖尿病肾病效果的临床观察[J]. 糖尿病新世界, 2016, 19(17): 129-130.
[19] 张俊秀. 中医辨治糖尿病肾病的临床疗效观察[J]. 中国医药指南, 2013(5): 286-287.
[20] 夏芃芃, 马进. 马进教授酒大黄治疗Ⅲ、Ⅳ期糖尿病肾病经验总结[J]. 中国中医药现代远程教育, 2021, 19(9): 99-101.
[21] Gao, Y. and Nan, Z. (2022) Mechanistic Insights into the Use of Rhubarb in Diabetic Kidney Disease Treatment Using Network Pharmacology. Medicine, 101, e28465. [Google Scholar] [CrossRef] 
[22] 刘庆阳, 于世家, 朱艳, 等. 大黄酸对肥胖糖尿病大鼠脂肪组织抵抗素基因表达及血浆游离脂肪酸水平的影响[J]. 中国糖尿病杂志, 2011, 19(5): 347-349.
[23] 吴芳莹, 魏军平. 黄连在糖尿病及相关肾脏疾病治疗中的效用机制研究[J]. 中国临床保健杂志, 2020, 23(3): 429-432.
[24] Hu, Q., Qu, C., Xiao, X., et al. (2021) Flavonoids on Diabetic Nephropathy: Advances and Therapeutic Opportunities. Chinese Medical Journal, 16, Article 74. [Google Scholar] [CrossRef] [PubMed]
[25] Hu, T., Yue, J., Tang, Q., et al. (2022) The Effect of Quercetin on Diabetic Nephropathy (DN): A Systematic Reviewand Meta-Analysis of Animal Studies. Food & Function, 13, 4789-4803. [Google Scholar] [CrossRef] 
[26] Vanaie, A., Shahidi, S., Iraj, B., et al. (2019) Curcumin as a Major Active Component of Turmeric Attenuates Proteinuria in Patients with Overt Diabetic Nephropathy. Journal of Research in Medical Sciences, 24, 1-6. [Google Scholar] [CrossRef] 
[27] Yang, H., Xu, W., Zhou, Z., Liu, J., et al. (2015) Curcumin Attenuates Urinary Excretion of Albumin in Type II Diabetic Patients with Enhancing Nuclear Factor Erythro-id-Derived 2-Like 2 (Nrf2) System and Repressing Inflammatory Signaling Efficacies . Experimental and Clinical Endocrinology & Diabetes, 123, 360-367. [Google Scholar] [CrossRef] [PubMed]
[28] 赵庆瑞. 雷公藤多苷联合羟苯磺酸钙治疗糖尿病肾病的临床观察[J]. 基层医学论坛, 2015(32): 4470-4471.
[29] Lv, C., Cheng, T., Zhang, B., et al. (2023) Triptolide Protects against Podocyte Injury in Diabetic Nephropathy by Activating the Nrf2/HO-1 Pathway and Inhibiting the NLRP3 Inflammasome Pathway. Renal Failure, 45, Article 2165103. [Google Scholar] [CrossRef] 
[30] 朱守斌, 桂军明, 操炎庆. 银杏叶胶囊结合胰岛素泵治疗糖尿病肾病尿蛋白的疗效及炎性应激指标变化分析[J]. 中国中西医结合肾病杂志, 2019, 20(11): 986-988.
[31] 彭佑武. 银杏叶提取物治疗早期糖尿病肾病的临床观察[J]. 国外医药(抗生素分册), 2014, 35(1): 13-14.
[32] Wei, M., Liu, Z., Liu, Y., et al. (2019) Urinary and Plasmatic Metabolomics Strategy to Explore the Holistic Mechanism of Lignans in S. Chinensis in Treating Alzheimer’s Disease Using UPLC-Q-TOF-MS. Food & Function, 10, 5656-5668. [Google Scholar] [CrossRef] 
[33] Weng, H., Han, W., Xiong, Y., et al. (2018) Taxus Chinensis Ameliorates Diabetic Nephropathy through Down-Regulating TGF-β1/Smad Pathway. Chinese Journal of Natural Medicines, 16, 90-96. [Google Scholar] [CrossRef] 
[34] 刘莹. 苓桂术甘汤联合小剂量多巴胺在糖尿病肾病透析性低血压预防中的作用[J]. 中医学报, 2017, 32(11): 2074-2077.
[35] 张晓燕, 杨朝清. 参芪地黄汤对气阴两虚型早期糖尿病肾病血清炎症因子、肾功能及微循环的影响[J]. 实用中医内科杂志, 2021, 35(3): 60-63.
[36] 王正. 金匮肾气丸加减治疗脾肾阳虚型糖尿病肾病的效果观察[J]. 黑龙江中医药, 2019, 48(5): 61-62.
[37] 胡静, 路建饶, 张冰冰, 陈杰, 廖琳, 何立群, 金珠. 益肾活血泄浊方联合陆氏针灸治疗糖尿病肾病中炎性细胞因子水平[J]. 世界中医药, 2019, 14(5): 1274-1277.
[38] 赵海京, 张秀媛, 倪青, 桂建华. 调理脾胃针法联合综合营养干预对糖尿病肾病患者肾功能的保护作用[J]. 世界中医药, 2021, 16(2): 307-310.
[39] 陈玉, 李娜, 孙德昱. 中药保留灌肠治疗糖尿病肾病Ⅳ期临床观察[J]. 山西中医, 2016, 32(1): 40-42.
[40] 胡丽娟, 中药保留灌肠治疗糖尿病肾病56例疗效观察及护理[J]. 中国民族民间医药, 2011, 20(12): 131-132.
[41] 沈伟, 健脾益肾泄浊方联合穴位贴敷治疗早中期糖尿病肾病疗效观察[J]. 中医药临床杂志, 2018, 30(1): 114-117.